The RxISK Prize, with a value of $100,000 USD, is offered to anyone who discovers a remedy for the persistent sexual side effects that occur after discontinuing the use of antidepressants, finasteride (Propecia), or isotretinoin (Accutane).

​

On September 12, 2017, RxISK initiated a campaign to raise $100,000 for this prize, which will be awarded to those who find a solution for PSSD, PFS, or PRSD.

​

The goal of $100,000 USD was achieved on December 14, 2020, by combining donations and commitments from 193 supporters across 24 countries.

​

Donations are managed by the Centre for Data-Based Medicine, a registered charity in England and Wales, and FJC - A Foundation of Philanthropic Funds.

​

Source: rxisk.org